3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Dermatologic
1
Conditions
Substance Withdrawal Syndrome
1
Opioid-Related Disorders
1
Lymphoma, Follicular
1
Interventions
Cyclophosphamide
139
Rituximab
114
Etoposide
77
Vincristine
75
Doxorubicin
62
Cytarabine
61
Dexamethasone
58
Prednisone
55
fludarabine
52
Methotrexate
46
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
42
Lenalidomide
36
Gemcitabine
35
Radiotherapy
29
Melphalan
27
pegaspargase
22
Prednisolone
22
Ifosfamide
22
fludarabine phosphate
20
Busulfan
20
Cisplatin
19
Bendamustine Hydrochloride
19
Asparaginase
18
Peripheral Blood Stem Cell Transplantation
17
Decitabine
16
Carmustine
16
ibrutinib
15
Mercaptopurine
15
Filgrastim
15
Oxaliplatin
14
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
salicylhydroxamic acid
×
Lymphoid
×
Clear all
NCT04850664
2021-08-06
CBOT-OUD
Evon Medics LLC
Phase 2
Unknown
190 enrolled